ACTIVE

AB PHARMA

Financial year 2024 · Closed on 31/12/2024

Net result36,6 k €-38,8 %over 1 year

Gross margin73,3 k €-30,4 %over 1 year

Equity486,9 k €+8,1 %over 1 year

Identity

Source · BCE/KBO

AB PHARMA is a Private limited company incorporated in 2006. Its main activity is: Management consultancy activities. Its registered office is in Oud-Turnhout.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0885.207.746
Incorporation: 24/11/2006
Legal form: Private limited company
Registered office: Beukenlaan 9
2360 Oud-Turnhout · FlandreSee on map
Contributed capital: 20 000,00 €
Latest accounts: 31/12/2024

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74142Specialised design activities

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

Financials

Source · NBB, 18 filings

Trend over 18 financial years

	2024		2023		2022		2021		2020
Income statement
Gross margin	73,3 k €	-30.4%	105,2 k €	+29.5%	81,2 k €	-31.3%	118,1 k €	+20.9%	97,7 k €
EBITDA	68,2 k €	-32.0%	100,3 k €	+30.7%	76,8 k €	-32.5%	113,6 k €	+21.5%	93,5 k €
Operating result	53,2 k €	-37.6%	85,3 k €	+38.2%	61,7 k €	-38.1%	99,8 k €	+18.4%	84,3 k €
Net result	36,6 k €	-38.8%	59,8 k €	+42.7%	41,9 k €	-34.0%	63,6 k €	+19.0%	53,4 k €
Balance sheet
Equity	486,9 k €	+8.1%	450,3 k €	+15.3%	390,5 k €	+12.0%	348,5 k €	+22.3%	285 k €
Total assets	844,5 k €	-1.3%	855,2 k €	-2.6%	877,9 k €	-0.9%	885,8 k €	+1.6%	872,2 k €
Cash	3,1 k €	+110%	1,5 k €	-34.6%	2,2 k €	+6.1%	2,1 k €	+135%	901 €
Debts	355,3 k €	-11.7%	402,6 k €	-17.0%	485,3 k €	-9.4%	535,4 k €	-8.5%	585,4 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Caroline Asselberghs	Director
Hilde Lydia Brouns	Director

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
HILDE BROUNS	Manager17/11/2006 → 2019 accountsDirector2022 accounts

Full financial information

Source · NBB

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/08/2025	17/07/2024	06/07/2023	29/08/2022	24/08/2021	08/10/2020
General meeting	07/06/2025	15/06/2024	03/06/2023	04/06/2022	05/06/2021	08/09/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	07/06/2025	29/08/2025	Dutch	PDF
Abridged model	31/12/2023	15/06/2024	17/07/2024	Dutch	PDF
Abridged model	31/12/2022	03/06/2023	06/07/2023	Dutch	PDF
Abridged model	31/12/2021	04/06/2022	29/08/2022	Dutch	PDF
Abridged model	31/12/2020	05/06/2021	24/08/2021	Dutch	PDF
Abridged model	31/12/2019	08/09/2020	08/10/2020	Dutch	PDF
Abridged model	31/12/2018	01/06/2019	30/07/2019	Dutch	PDF
Abridged model	31/12/2017	02/06/2018	25/06/2018	Dutch	PDF
Abridged model	31/12/2016	03/06/2017	08/06/2017	Dutch	PDF
Abridged model	31/12/2015	04/06/2016	14/06/2016	Dutch	PDF
Abridged model	31/12/2014	06/06/2015	21/08/2015	Dutch	PDF
Abridged model	31/12/2013	07/06/2014	13/06/2014	Dutch	PDF
Abridged model	31/12/2012	01/06/2013	10/06/2013	Dutch	PDF
Abridged model	31/12/2011	02/06/2012	10/07/2012	Dutch	PDF
Abridged model	31/12/2010	25/06/2011	28/06/2011	Dutch	PDF
Abridged model	31/12/2009	26/06/2010	02/07/2010	Dutch	PDF
Abridged model	31/12/2008	27/06/2009	18/08/2009	Dutch	PDF
Abridged model	31/12/2007	07/06/2008	20/08/2008	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 1 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Caroline Asselberghs	Director
Hilde Lydia Brouns	Director

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
HILDE BROUNS	Manager17/11/2006 → 2019 accountsDirector2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office08/12/2025
MAATSCHAPPELIJKE ZETEL
PDF
Mandates14/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Other04/12/2006
Oprichting
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings18 filings

Mandates

Hilde Lydia Brouns

Caroline Asselberghs

HILDE BROUNS

200620072008200920102011201220132014201520162017201820192020202120222023202420252026

AB PHARMA

Scheltjenseinde 5, 2340 Beerse

Director

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Beukenlaan 9, 2360 Oud-TurnhoutCurrent		CBE
Scheltjenseinde 5, 2340 Beerse	accounts 2021 → 2024	Accounts 2024 · 2025-00432643

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
AB PHARMACurrent	accounts 2021 → 2024	Accounts 2024 · 2025-00432643

Events

2024
Annual accounts 202436,6 k €↓
2023
Annual accounts 202359,8 k €↑
2022
Annual accounts 202241,9 k €↓
2021
Annual accounts 202163,6 k €↑
2020
Annual accounts 202053,4 k €↑
2019
Annual accounts 201949,4 k €↑
2018
Annual accounts 201825,5 k €↑
2017
Annual accounts 201721,3 k €↓
2016
Annual accounts 201622,5 k €↑
2015
Annual accounts 201518,6 k €↓
2014
Annual accounts 201422,8 k €↑
2013
Annual accounts 201310,6 k €↓
2012
Annual accounts 201215,8 k €↑
2011
Annual accounts 201114,6 k €↑
2010
Annual accounts 201011,8 k €↓
2009
Annual accounts 200913,2 k €↓
2008
Annual accounts 200814,7 k €↑
2007
Annual accounts 2007-18,8 k €
24/11/2006
IncorporationPrivate limited company

AB PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events